The Viral Epidemiology Branch has used a variety of approaches to define the nature and magnitude of HIV-1 associated malignancies, including analyses of population-based cancer registries, death certificates, prospective cohorts, and laboratory studies. A major focus in the past year has been on Kaposi's sarcoma and its associated DNA virus, HHV8. VEB researchers reported that multiple lesions of this tumor share the same clonal origin, further establishing Kaposi's sarcoma as a true malignant neoplasm. To clarify discrepancies in reported seroepidemiology of HHV8 infection, we sent a blinded test panel to six leading laboratories and found poor agreement among current HHV8 antibody assays, particularly for sera from normal blood donors. In a collaborative study, HHV8 seropositivity was found to be positively associated with measures of sexual activity, such as frequency of receptive anal intercourse. These studies indicate that serologic assays are contributing to epidemiologic investigations of HHV8, but are as yet inadequate for determining infection prevalence in individuals at low risk for Kaposi's sarcoma. The AIDS-Cancer Match Registry continues to contribute to our understanding of the spectrum of AIDS malignancies, and recent analyses identify seminoma, multiple myeloma, and brain cancer as increased in incidence in patients with AIDS. A similar analysis of U.S. death registrations identified several additional HIV-associated tumors with lower relative risk, although brain cancer was not increased in that study. Among reported anal cancer cases in San Francisco men age 25-54, approximately half were associated with AIDS, but the relative risk (if any) appears to be small in comparison to the relative risk associated with male homosexuality. Circulating lymphocytes with the Burkitt's lymphoma-associated t(8;14) translocation were found to be increased with duration of HIV infection, whereas the follicular lymphoma-associated t(14;18) translocation was not increased in HIV infection.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Intramural Research (Z01)
Project #
1Z01CP005781-03
Application #
6161625
Study Section
Special Emphasis Panel (VEB)
Project Start
Project End
Budget Start
Budget End
Support Year
3
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Division of Cancer Epidemiology and Genetics
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Biggar, R J; Frisch, M; Goedert, J J (2000) Risk of cancer in children with AIDS. AIDS-Cancer Match Registry Study Group. JAMA 284:205-9
Zhang, Y J; Deng, J H; Rabkin, C et al. (2000) Hot-spot variations of Kaposi's sarcoma-associated herpesvirus latent nuclear antigen and application in genotyping by PCR-RFLP. J Gen Virol 81:2049-58
Engels, E A; Frisch, M; Biggar, R J et al. (2000) AIDS-Related opportunistic illness and potent antiretroviral therapy. JAMA 283:2653-4
Rabkin, C S (2000) The need for investigations of prophylactic regimens to prevent AIDS-associated non-Hodgkin's lymphoma. Clin Infect Dis 30:762-3
Frisch, M; Biggar, R J; Goedert, J J (2000) Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 92:1500-10
Biggar, RJ; Frisch, M (2000) Estimating the Risk of Cancer in Children With AIDS. JAMA 284:2593-2594
Zong, J C; Ciufo, D M; Alcendor, D J et al. (1999) High-level variability in the ORF-K1 membrane protein gene at the left end of the Kaposi's sarcoma-associated herpesvirus genome defines four major virus subtypes and multiple variants or clades in different human populations. J Virol 73:4156-70
Rabkin, C S (1999) Epidemiology of B-cell lymphomas. Curr Top Microbiol Immunol 246:235-9;discussion 240
Rabkin, C S; Sei, S (1999) Susceptibility genes for AIDS and AIDS-related lymphoma. Curr Top Microbiol Immunol 246:111-4;discussion 115
Rabkin, C S; Testa, M A; Huang, J et al. (1999) Kaposi's sarcoma and non-Hodgkin's lymphoma incidence trends in AIDS Clinical Trial Group study participants. J Acquir Immune Defic Syndr 21 Suppl 1:S31-3

Showing the most recent 10 out of 13 publications